RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $40.2b | $282.33 | +1.6% | 818.5K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $13.1b | $54.76 | +0.4% | 2.5M |
 ARWR | Arrowhead Research Corporation | $11.5b | $70.51 | -2.0% | 1.4M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.1b | $5.64 | -4.7% | 1.4M |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $306.2m | $8.32 | -5.9% | 84.8K |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $256.8m | $1.69 | -4.8% | 365.7K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $230.1m | $12.14 | -1.1% | 110.2K |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $226.9m | $3.96 | -4.4% | 94.9K |
 XCUR | Exicure, Inc. Common Stock | $13.3m | $1.66 | -3.4% | 339.0K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $11.9m | $0.99 | +12.3% | 865.4K |